https://www.selleckchem.com/ph....armacological_epigen
No adverse events were reported. At the end of intervention, the ESPVM group presented higher frequencies of complete visual tracking for cards 7 (ESPVM = 57.3 %, SC = 6.3 %, p = 0.006) and 8 (ESPVM = 64.3 %, SC = 12.2 %, p = 0.013), and lower scores for total sensory profile (ESPVM median = 58, range = 46-69; SC median = 71, range = 54-90; p = 0.016). The groups were similar for motor development. The protocol was feasible, and the results encourage a larger randomized controlled trial. The protocol was feasible, and the res
Like
Comment
Share
